Thank you, Acumen Blog readers, for another successful year! We recently surpassed the 7th anniversary of the Acumen Blog, and we are very appreciative to have had you along for the ride. In … [Read more...]
Nephrology News Roundup
Here’s a roundup of nephrology news over the past couple weeks. Click on the headlines to browse the articles. Or, if you’ve discovered other newsworthy items that may be of interest to our team or … [Read more...]
Nephrology News Roundup
Here’s a roundup of nephrology news over the past couple weeks. Click on the headlines to browse the articles. Or, if you’ve discovered other newsworthy items that may be of interest to our team or … [Read more...]
Get Ready for the Acumen Connect Users Conference—August 8–11
Our team at Acumen is looking forward to the start of the biggest Acumen Connect Users Conference yet, and we can’t wait to welcome everyone to Nashville! Music City is not only home to Southern … [Read more...]
Nephrology News Roundup
Chronic Kidney Disease (CKD) Drugs - Global Market Outlook (2017-2023) According to Stratistics MRC, the Global Chronic Kidney Disease (CKD) Drugs market is expected to grow from $12.87 billion in … [Read more...]
Nephrology News Roundup
Here’s a roundup of nephrology news over the past couple weeks. Click on the headlines to browse the articles. Or, if you’ve discovered other newsworthy items that may be of interest to our team or … [Read more...]
Nephrology News Roundup
Here’s a roundup of nephrology news over the past couple weeks. Click on the headlines to browse the articles. Or, if you’ve discovered other newsworthy items that may be of interest to our team or … [Read more...]
Intravenous Form of Sensipar® Has Been Approved by the FDA
Parsabiv™ (etelcalcetide), an IV formulation similar to the oral calcimimetic Sensipar® (cinicalset), was recently approved by the U.S. Food and Drug Administration to treat secondary … [Read more...]
